Der Markt für Anaphylaxiebehandlungen wird im Jahr 2028 voraussichtlich 4.787,66 Millionen US-Dollar erreichen, gegenüber 2.664,66 Millionen US-Dollar im Jahr 2021; Es wird geschätzt, dass es im Zeitraum 20212028 mit einer jährlichen Wachstumsrate von 8,7 % wachsen wird.
Anaphylaxie ist eine allergische Reaktion, die zu einem tödlichen Zustand führen kann, der als anaphylaktischer Schock bekannt ist. Eine Anaphylaxie tritt auf, wenn der Körper des Patienten auf eine Fremdsubstanz reagiert und eine große Menge Histamin produziert, die eine Entzündungsreaktion auslöst. Nach Angaben der Asthma and Allergy Foundation of America (AAFA) gibt es in den USA jedes Jahr rund 200.000 Krankenhausbesuche aufgrund von Nahrungsmittelallergien. Das Wachstum des Marktes für die Behandlung von Anaphylaxie wird auf Faktoren wie die steigende Inzidenz von Anaphylaxie und die jüngsten Zulassungen von Adrenalin zurückgeführt. Allerdings behindert der schlechte Zugang zu Adrenalin-Autoinjektoren in Ländern mit niedrigem Einkommen das Marktwachstum.
Lukrative Regionen für den Markt für Anaphylaxie-Behandlung
Markteinblicke
Steigende Häufigkeit von Anaphylaxie
Anaphylaxie ist eine schwere, lebensbedrohliche allergische Reaktion, die durch die Anfälligkeit für Allergene (Nahrungsmittel, Insektenstiche oder Medikamente) verursacht wird, die vom menschlichen Körper als körperfremd erkannt werden . Typische Anzeichen dieser Erkrankung sind Schluck- und Atembeschwerden, Hautrötung und Juckreiz, beschleunigter Herzschlag, pfeifende Atmung, schnelle Atmung und sinkender Blutdruck. Die Häufigkeit von Anaphylaxie nimmt weltweit zu. Nach Angaben des National Institute for Health and Care Excellence (NICE) verursacht Anaphylaxie im Vereinigten Königreich jedes Jahr mehr als 20 Todesfälle. Nach Angaben der European Academy of Allergy and Clinical Immunology leiden jedes Jahr etwa 150 Millionen Europäer an chronischen allergischen Erkrankungen. Daher führt die steigende Inzidenz von Allergien zu einem Anstieg der Anaphylaxiefälle. Darüber hinaus leiden laut den Allergy Facts des American College of Allergy, Asthma & Immunology jedes Jahr mehr als 50 Millionen Menschen an verschiedenen Arten von Allergien.
115 % der US-Bevölkerung haben das Risiko einer anaphylaktischen Reaktion, wenn sie einem oder mehreren Allergenen ausgesetzt sind, und bis zu 1 % dieser Patienten sterben aufgrund einer Anaphylaxie. Die Erkrankung führt in den USA zu etwa 1.500 Todesfällen pro Jahr; Allergien werden außerdem als sechsthäufigste Ursache chronischer Erkrankungen aufgeführt. Darüber hinaus ist nach Angaben der Asthma and Allergy Foundation of America (AAFA) aufgrund zunehmender Nahrungsmittelallergien die Zahl der Krankenhausbesuche gestiegen. Nahrungsmittelallergien sind die Ursache für mehr als 200.000 Besuche in der Notaufnahme pro Jahr. Laut Food Allergy Research & Education leben mehr als 32 Millionen Amerikaner mit lebensbedrohlichen Nahrungsmittelallergien. Aufgrund der zunehmenden Verbreitung von Allergien nimmt die wirtschaftliche Belastung der Gesundheitssysteme in vielen Ländern zu. Laut Allergy Facts belaufen sich die jährlichen Kosten für die Behandlung von Allergiefällen in den USA beispielsweise auf mehr als 18 Milliarden US-Dollar. Somit treibt die zunehmende Inzidenz von Anaphylaxie das Wachstum des Marktes voran.
Medikamententyp-basierte Erkenntnisse
Basierend auf dem Medikamententyp ist der Markt für Anaphylaxiebehandlungen in Adrenalin, Antihistaminika und Medikamente unterteilt. Steroide, Beta-Agonisten und andere. Das Epinephrin-Segment hatte im Jahr 2020 den größten Marktanteil und wird im Prognosezeitraum voraussichtlich die höchste CAGR auf dem Markt verzeichnen.
Markt für Anaphylaxiebehandlung, nach Medikamententyp 2020 und 2028
Weg der Verabreichung basierend auf Erkenntnissen
Basierend auf dem Weg der Verabreichung ist der Markt für Anaphylaxiebehandlung in orale, parenterale und andere unterteilt. Das parenterale Segment hatte im Jahr 2020 den größten Marktanteil, während das orale Segment im Prognosezeitraum voraussichtlich die höchste CAGR von 8,9 % auf dem Markt verzeichnen wird.
Erkenntnisse zum Allergietyp
Basierend auf dem Allergietyp ist der Markt für Anaphylaxiebehandlungen in Nahrungsmittelallergien, Medikamente, Insektenstiche und andere unterteilt. Das Segment Lebensmittelallergien hatte im Jahr 2020 den größten Marktanteil und wird im Prognosezeitraum voraussichtlich die höchste CAGR auf dem Markt verzeichnen.
Vertriebskanalbasierte Erkenntnisse
Basierend auf Aufgrund seines Vertriebskanals ist der Markt für Anaphylaxie-Behandlungen in Krankenhausapotheken, Einzelhandel, Drogeriepost und andere unterteilt. Das Einzelhandelsumsatzsegment hatte im Jahr 2020 den größten Marktanteil und wird im Prognosezeitraum voraussichtlich die höchste CAGR auf dem Markt verzeichnen.
Strategische Einblicke
Produkteinführungen und -zulassungen sind die allgemein angenommenen Strategien von Unternehmen zur Erweiterung ihrer globalen Präsenz und ihres Produktportfolios. Darüber hinaus konzentrieren sich die Marktteilnehmer für Anaphylaxiebehandlungen auf die Strategie der Zusammenarbeit, um ihren Kundenkreis zu vergrößern, was ihnen wiederum ermöglicht, ihren Markennamen weltweit aufrechtzuerhalten.
Markt für Anaphylaxiebehandlungen nach Medikamententyp
< ul>
Markt für Anaphylaxie-Behandlung nach Verabreichungsweg
- Oral
- Parenteral
- Andere
Markt für Anaphylaxie-Behandlung - nach Allergietyp
- Nahrungsmittelallergie
- Medikamente
- Insektenstiche
- Andere
- Krankenhausapotheken
- Einzelhandelsumsätze
- Andere
Anaphylaxie Behandlungsmarkt nach Geografie
- Nordamerika
- USA
- Kanada
- Mexiko
- Europa
- Frankreich
- Deutschland
- Italien
- Großbritannien
- Spanien < li>Übriges Europa
- China
- Indien
- Südkorea< /li>
- Japan
- Australien
- Übriger Asien-Pazifik-Raum
- Südafrika
- Saudi-Arabien
- VAE
- Übriger Naher Osten und Afrika
- Brasilien
- Argentinien
- Übriges Süd- und Mittelamerika
Unternehmensprofile
- Amneal Pharmaceuticals Inc.
- Bioprojet
- Mylan NV
- Adamis Pharmaceutical Corporation
- Abbott
- Pfizer Inc.
- Glaxosmithkline Plc.
- Merck And Co., Inc.
- Teva Pharmaceutical Industries Ltd.
- ALK-ABELLó
Report Coverage
Revenue forecast, Company Analysis, Industry landscape, Growth factors, and Trends
Segment Covered
This text is related
to segments covered.
Regional Scope
North America, Europe, Asia Pacific, Middle East & Africa, South & Central America
Country Scope
This text is related
to country scope.
Frequently Asked Questions
Anaphylaxis is an allergic reaction that can further lead to a fatal condition known as anaphylactic shock. Anaphylaxis occurs when the patient's body reacts to a foreign substance and produces a high amount of histamine that triggers an inflammatory response.
The growth of the anaphylaxis treatment market is attributed to the factors such as rising incidence of anaphylaxis, and recent approvals of epinephrine. Moreover, rise in cases of allergies post administration of covid-19 vaccines is also favoring the growth of the market
The anaphylaxis treatment market majorly consists of the players such as Amneal Pharmaceuticals Inc., Bioprojet, Mylan N.V., Adamis Pharmaceutical Corporation, Abbott, Pfizer Inc., Glaxosmithkline Plc., Merck And Co. Inc., Teva Pharmaceutical Industries Ltd., ALK-ABELLó among others.
The List of Companies - Anaphylaxis Treatment Market
- Amneal Pharmaceuticals Inc.
- Bioprojet
- Mylan N.V.
- Adamis Pharmaceutical Corporation
- Abbott
- Pfizer Inc.
- Glaxosmithkline Plc.,
- Merck And Co., Inc.
- Teva Pharmaceutical Industries Ltd.
- ALK-ABELLó
The Insight Partners performs research in 4 major stages: Data Collection & Secondary Research, Primary Research, Data Analysis and Data Triangulation & Final Review.
- Data Collection and Secondary Research:
As a market research and consulting firm operating from a decade, we have published and advised several client across the globe. First step for any study will start with an assessment of currently available data and insights from existing reports. Further, historical and current market information is collected from Investor Presentations, Annual Reports, SEC Filings, etc., and other information related to company’s performance and market positioning are gathered from Paid Databases (Factiva, Hoovers, and Reuters) and various other publications available in public domain.
Several associations trade associates, technical forums, institutes, societies and organization are accessed to gain technical as well as market related insights through their publications such as research papers, blogs and press releases related to the studies are referred to get cues about the market. Further, white papers, journals, magazines, and other news articles published in last 3 years are scrutinized and analyzed to understand the current market trends.
- Primary Research:
The primarily interview analysis comprise of data obtained from industry participants interview and answers to survey questions gathered by in-house primary team.
For primary research, interviews are conducted with industry experts/CEOs/Marketing Managers/VPs/Subject Matter Experts from both demand and supply side to get a 360-degree view of the market. The primary team conducts several interviews based on the complexity of the markets to understand the various market trends and dynamics which makes research more credible and precise.
A typical research interview fulfils the following functions:
- Provides first-hand information on the market size, market trends, growth trends, competitive landscape, and outlook
- Validates and strengthens in-house secondary research findings
- Develops the analysis team’s expertise and market understanding
Primary research involves email interactions and telephone interviews for each market, category, segment, and sub-segment across geographies. The participants who typically take part in such a process include, but are not limited to:
- Industry participants: VPs, business development managers, market intelligence managers and national sales managers
- Outside experts: Valuation experts, research analysts and key opinion leaders specializing in the electronics and semiconductor industry.
Below is the breakup of our primary respondents by company, designation, and region:
Once we receive the confirmation from primary research sources or primary respondents, we finalize the base year market estimation and forecast the data as per the macroeconomic and microeconomic factors assessed during data collection.
- Data Analysis:
Once data is validated through both secondary as well as primary respondents, we finalize the market estimations by hypothesis formulation and factor analysis at regional and country level.
- Macro-Economic Factor Analysis:
We analyse macroeconomic indicators such the gross domestic product (GDP), increase in the demand for goods and services across industries, technological advancement, regional economic growth, governmental policies, the influence of COVID-19, PEST analysis, and other aspects. This analysis aids in setting benchmarks for various nations/regions and approximating market splits. Additionally, the general trend of the aforementioned components aid in determining the market's development possibilities.
- Country Level Data:
Various factors that are especially aligned to the country are taken into account to determine the market size for a certain area and country, including the presence of vendors, such as headquarters and offices, the country's GDP, demand patterns, and industry growth. To comprehend the market dynamics for the nation, a number of growth variables, inhibitors, application areas, and current market trends are researched. The aforementioned elements aid in determining the country's overall market's growth potential.
- Company Profile:
The “Table of Contents” is formulated by listing and analyzing more than 25 - 30 companies operating in the market ecosystem across geographies. However, we profile only 10 companies as a standard practice in our syndicate reports. These 10 companies comprise leading, emerging, and regional players. Nonetheless, our analysis is not restricted to the 10 listed companies, we also analyze other companies present in the market to develop a holistic view and understand the prevailing trends. The “Company Profiles” section in the report covers key facts, business description, products & services, financial information, SWOT analysis, and key developments. The financial information presented is extracted from the annual reports and official documents of the publicly listed companies. Upon collecting the information for the sections of respective companies, we verify them via various primary sources and then compile the data in respective company profiles. The company level information helps us in deriving the base number as well as in forecasting the market size.
- Developing Base Number:
Aggregation of sales statistics (2020-2022) and macro-economic factor, and other secondary and primary research insights are utilized to arrive at base number and related market shares for 2022. The data gaps are identified in this step and relevant market data is analyzed, collected from paid primary interviews or databases. On finalizing the base year market size, forecasts are developed on the basis of macro-economic, industry and market growth factors and company level analysis.
- Data Triangulation and Final Review:
The market findings and base year market size calculations are validated from supply as well as demand side. Demand side validations are based on macro-economic factor analysis and benchmarks for respective regions and countries. In case of supply side validations, revenues of major companies are estimated (in case not available) based on industry benchmark, approximate number of employees, product portfolio, and primary interviews revenues are gathered. Further revenue from target product/service segment is assessed to avoid overshooting of market statistics. In case of heavy deviations between supply and demand side values, all thes steps are repeated to achieve synchronization.
We follow an iterative model, wherein we share our research findings with Subject Matter Experts (SME’s) and Key Opinion Leaders (KOLs) until consensus view of the market is not formulated – this model negates any drastic deviation in the opinions of experts. Only validated and universally acceptable research findings are quoted in our reports.
We have important check points that we use to validate our research findings – which we call – data triangulation, where we validate the information, we generate from secondary sources with primary interviews and then we re-validate with our internal data bases and Subject matter experts. This comprehensive model enables us to deliver high quality, reliable data in shortest possible time.
Related Reports
Jun 2021
Aquatic Veterinary Market
Size and Forecast (2020 - 2030), Global and Regional Share, Trend, and Growth Opportunity Analysis Report Coverage: By Type (Diagnostics and Treatments), Species (Fish, Crustaceans, Mollusca, and Others), Disease Source (Bacteria, Viruses, Parasites, and Others), Route of Administration (Water Medication, Medicated Feed, and Others), and Geography (North America, Europe, Asia Pacific, Middle East & Africa, and South & Central America)
Jun 2021
Sickle Cell Disease Treatment Market
Size and Forecasts (2020 - 2030), Global and Regional Share, Trends, and Growth Opportunity Analysis By Treatment (Generic Drugs and Originators), Route of Administration (Oral and Parenteral), and Distribution Channel (Direct Tender, Hospital Pharmacies, Retail Pharmacies, Online Pharmacies, and Others)
Jun 2021
Malaria and Sickle Cell Disease Treatment Market
Size and Forecasts (2020 - 2030), Global and Regional Share, Trends, and Growth Opportunity Analysis Report Coverage: By Treatment [Malaria and Sickle Cell Disease (SCD)], Route of Administration (Oral and Parenteral), and Distribution Channel (Direct Tender, Hospital Pharmacies, Retail Pharmacies, Online Pharmacies, and Others)
Jun 2021
Pharmaceutical Contract Sales Organizations Market
Size and Forecasts (2020 - 2030), Global and Regional Share, Trends, and Growth Opportunity Analysis Report Coverage: By Services (Commercial Services and Non-Commercial Services), Modules (Syndicated Modules and Dedicated Modules), Therapeutic Area (Cardiovascular Disorders, Oncology, Metabolic Disorders, Neurology, Orthopedic Diseases, Infectious Diseases, and Others), End User (Biopharmaceutical Companies and Pharmaceutical Companies), and Geography (North America, Europe, Asia Pacific, Middle East & Africa, and South & Central America)
Jun 2021
Breast Cancer Therapeutics Market
Size and Forecasts (2020 - 2030), Global and Regional Share, Trends, and Growth Opportunity Analysis Report Coverage: By Drug Therapy [Targeted Drug Therapy (Abemaciclib, Ado-Trastuzumab Emtansine, Palbociclib, Trastuzumab, and Other Target Drug Therapies), Hormonal Drug Therapy (Selective Estrogen Receptor Modulators, Aromatase Inhibitors, and Selective Estrogen Receptor Downregulators), Chemotherapy, and Immunotherapy/Biological Therapy], Breast Cancer Type (Hormone Receptor, HER2+, and Triple-Negative Breast Cancer), Distribution Channel (Hospital Pharmacies, Drug Stores and Retail Pharmacies, and Online Pharmacies), and Geography (North America, Europe, Asia Pacific, Middle East & Africa, and South & Central America)
Jun 2021
Radioactive Tracer Market
Size and Forecast to 2030 - Global Analysis by Tracer Type [Technetium-99m & Tc-97m, Iodine-131, Iron-59, Lutetium-171, Rubidium (Rb-82) Chloride & Ammonia (N-13), Scandium-46, Seaborgium-269, Hassium-269, Gallium Citrate Ga 67, Prostate-Specific Membrane Antigen (PSMA) (Ga-68), FDDNP (F-18) & FDOPA (F-18), Phosphorus-32 & Chromium-51, Thallium-201, F-18 FDG, F-18 FAPI, Ga-68 FAPI, F-18 PSMA, DOTATOC/DOTANOC/DOTATATE (Ga-68), and Others], Test Type (PET, SPECT, and Others), Application (Oncology, Pulmonary, Neurology, Cardiology, and Others) End User (Hospitals & Clinics, Diagnostic Centers, Academic & Research Institutes, And Others), and Geography
Jun 2021
Glioma Treatment Market
Size and Forecasts (2020 - 2030), Global and Regional Share, Trends, and Growth Opportunity Analysis Report Coverage: By Disease (Astrocytoma, Oligoastrocytoma, and Oligodendroglioma), Treatment Type (Surgery, Chemotherapy, Radiation Therapy, and Others), Grade (Low Grade and High Grade), End User (Hospital & Clinics and Ambulatory Surgical Center), and Geography
Jun 2021
Hyperpigmentation Disorder Treatment Market
Size and Forecast (2020 - 2030), Global and Regional Share, Trend, and Growth Opportunity Analysis Report Coverage: By Treatment Type (Cosmeceutical, Light or Laser Therapy, Microdermabrasion, Chemical Peels, Cryotherapy, and Others), Condition (Melasma, Solar Lentigines, Post-Inflammatory Hyperpigmentation, and Others), End User (Hospitals, Dermatology Centers, and Others), and Geography (North America, Europe, Asia Pacific, South & Central America, and Middle East & Africa)